Hoseob Kim
Papers
1
Total Citations
2
H-Index
1
About
Hoseob Kim is a leading urological researcher whose work focuses on improving prostate cancer (PCa) detection through large-scale, real-world data analysis. His key research areas include the impact of 5-alpha reductase inhibitors (5ARIs) on cancer screening, the optimization of PSA testing protocols, and the epidemiology of urological cancers in Asian populations. Kim’s most notable contribution is his decade-long (2007–2016) nationwide observational study in Korea, which demonstrated that 5ARI use significantly enhances PCa detection by creating more opportunities for repeated PSA testing—a critical finding given the historically low screening uptake among Korean men. This work, published in 2023, has already garnered 2 citations and is shaping clinical guidelines for chemoprevention and early diagnosis. By leveraging national health databases, Kim provides evidence-based strategies to reduce diagnostic delays and improve outcomes. His research bridges the gap between pharmacology and public health, offering actionable insights for urologists and policymakers. For students and researchers, Kim’s work exemplifies how longitudinal, population-level studies can transform cancer screening practices and highlights the importance of tailoring detection strategies to specific demographic and healthcare contexts.
Research Focus
Key Achievements
Top Papers
- 1